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Hepatitis is a major health problem in both developing and developed countries and viral hepatitis is the most common cause of hepatitis in children. Among the 
hepatotropic viruses, hepatitis A virus (HAV) and hepatitis E virus 
(HEV) are enterically transmitted and hepatitis B virus (HBV), 
hepatitis C virus (HCV), and hepatitis D virus are parenterally 
transmitted [1]. In India, HAV and HEV infections have assumed 
endemic proportions. HAV mainly affects children, whereas 
HEV is more common among young adults [2]. In developing 
countries, HAV constitutes approximately two-third of sporadic 
acute viral hepatitis (AVH) in children [3]. Greater awareness and 
availability of laboratory diagnosis has resulted in identifying 
HEV as an important cause of sporadic AVH even in children (up 
to 59%) [4]. In India and other developing countries, HAB is also 
common (3–34%) among children with sporadic AVH [5].
In preschoolers, HAV is the most frequent cause of hepatitis [6]. 
It was reported that HAV infection in children usually exhibits 
mild nonspecific symptoms and low case fatality in comparison 
to adults [7]. In general, HAE resembles HAV, having similar 
routes of transmission and clinical picture. However, it has a 
longer incubation period and affects older children and adults and 
is responsible for significant number of cases of sporadic hepatitis 
and is an important cause of acute liver failure (ALF) [8].
Large annual epidemics are attributed to HEV, and studies 
suggest that it is etiologically responsible for 10–95% of admitted 
cases of hepatitis across South Asia [9]. Due to the use of HAV 
vaccine, HEV is now emerging as an important cause of AVH [10]. 
The aim of this study was to estimate the proportion of hepatitis 
A and E as a causative agent in children presenting with acute 
hepatitis and to study their clinical and biochemical parameters.
MATERIALS AND METHODS
This observational hospital-based study was conducted in the 
department of pediatrics medicine of a tertiary center of Western 
India, a large teaching hospital in Jaipur, the capital city of 
Rajasthan, India. Children attending to or admitted in the hospital 
with clinical features of acute hepatitis defined as hepatomegaly, 
fever >38°C, malaise, dark urine, and/or jaundice were enrolled 
after taking written informed consent from parents/guardian. 
ABSTRACT
Background: Hepatitis is a major health problem in both developing and developed countries, with various infective and non-
infective causes. Aim: This study aims to estimate the proportion of hepatitis A and E as a causative agent in children presenting 
with acute hepatitis and to study their clinical and biochemical parameters. Materials and Methods: The present study was 
conducted on all children attending or admitted with clinical features of acute hepatitis defined as hepatomegaly, fever >38°C, 
malaise, dark urine, and/or jaundice. All children included were clinically examined and relevant investigations were sent. All the 
data were entered in a structured pro forma and statistical analysis was done. Results: A total of 254 patients were studied. Hepatitis 
A virus (HAV) was the most common with 95.08% of cases and occurred in the age group of ≤5 years. Hepatitis E virus (HEV) was 
more common in ≥10 years age group and was observed in 13.11% of cases. Common prodromal symptoms in hepatitis patients 
were fever, anorexia, vomiting, and abdominal pain, observed in 82.5%, 32.5%, 55.5%, and 50.5% of cases, respectively, with no 
significant difference between HAV and HEV. In liver biochemistry, there was no significant difference in serum bilirubin, serum 
glutamic oxaloacetic transaminase, and serum glutamate pyruvate transaminase values between HAV and HEV. Conclusion: There 
are no significant differences in both enterically-transmitted hepatitis viruses and the only way to differentiate between them is by 
serological tests.
Key words: Bilirubin, Hepatitis, Hepatitis A virus, Hepatitis E virus, Serum glutamate pyruvate transaminase, Serum glutamic 
oxaloacetic transaminase
Semwal et al. Proportion of hepatitis A and E among children with viral hepatitis
Online First Indian J Child Health 2
Sample size was calculated at 80% study power and alpha error 
0.05 assuming the occurrence of hepatitis A and E separately as 
15% according to the results obtained in seed article.
The inclusion criteria applied in case selection were onset 
of symptoms <12 weeks, age >6 months–<18 years, total serum 
bilirubin >2 mg/dl, and aspartate aminotransferase/alanine 
aminotransferase >200 IU/L. Exclusion criteria were patients with 
liver disease who were undergoing treatment with a hepatotoxic 
drug and patient with acute hepatitis due to metabolic errors and 
autoimmunity.
All the details were recorded using a uniform medical 
questionnaire and details about significant past and family history 
were taken. Vitals were recorded and temperature was measured 
by digital thermometer. Systemic examination was carried out 
particularly of abdomen and central nervous system examination. 
All subjects were investigated for complete blood count, serum 
bilirubin, serum glutamic oxaloacetic transaminase (SGOT), 
serum glutamate pyruvate transaminase (SGPT), prothrombin 
time, and international normalized ratio (INR), and viral marker 
serology. All the data were entered into structured pro forma and 
statistical analysis was done.
Human serum or plasma collected was used as sample. After 
blood collection, serum was separated from the clot as soon 
as possible. If the assay was performed within 48 h of sample 
collection, the samples were kept at 2–8°C; otherwise, deep-
frozen (−20°C or below) storage was done. The presence or 
absence of immunoglobulin M (IgM) anti-HAV was determined 
by comparing the absorbance value of unknown samples to that of 
the cutoff value. Complete blood count was done by autoanalyzer. 
Liver biochemistry – SGOT and SGPT were done by kit of ERBA 
Diagnostics Mannheim GmbH (Germany). PT/INR was done by 
NEOPLASTINE CI PLUS.
DiaSorin S.p.A. (Italy) ETI-HA-IGMK-PLUS No 142 was used 
for estimating IgM antibodies of hepatitis A. DIA.PRO (Diagnostic 
Bioprobes Srl, Italy) ELISA kit was used for the determination of 
IgM antibodies to HEV in human serum and plasma. HEPACARD 
(Diagnostic Enterprises, India) was used for the one-step rapid 
visual qualitative detection of hepatitis B surface antigen (HBsAg) 
in human serum/plasma. HCV TRI-DOT (Diagnostic Enterprises, 
India) kit was used for rapid visual qualitative detection of 
antibodies to hepatitis C in human serum/plasma.
All the data were entered into Master Chart prepared in 
Microsoft Excel 2007 and statistical analysis was done using 
Microsoft Excel, Chi-square test and unpaired t-test using 
statistics calculator Stat Pac version 3.
RESULTS
Out of the 254 patients enrolled in the study, 200 were viral 
marker positive. HAV was the most common virus implicated in 
AVH causing 66.92% of cases followed by HBV 6.69% and HEV 
5.90% (Table 1).
There was no statistically significant difference in the sex-wise 
distribution in HAV and HEV infection. The highest proportion 
of cases of hepatitis A was in the age group of ≤5 years with 
95.08% of the total marker positive patients, whereas the highest 
proportion of cases of hepatitis E was seen in the age group of 
≥10 years with 13.11% (p<0.05) (Table 2).
Prodromal phase symptoms of AVH were compared between 
enterically-transmitted hepatitis and statistical analysis was 
done.
As shown in the Table 3, most  common prodromal 
symptoms in hepatitis patients were fever, anorexia, vomiting, 
and abdominal pain with 82.5%, 32.5%, 55.5%, and 50.5%, 
respectively. It was seen that in prodromal phase of hepatitis, the 
non-specific symptoms were not significantly different (p>0.05). 
There was no significant difference among jaundice, bleeding, 
and encephalopathy manifestation in hepatitis A and E patients 
(p>0.05).
Liver biochemistry in relation to serum bilirubin, SGOT, 
SGPT, and coagulopathy showed no significant difference 
between HAV and HEV. Similarly, there was no significant 
difference in significant coagulopathy and etiological agent 
(p>0.05) as per the Table 4. Out of the 63 cases of ALF, 42 cases 
(66.67%) were due to hepatitis A and 1 case (1.5%) was due to 
hepatitis E.
Table 1: Distribution of total cases of acute hepatitis in the study 
population
Acute hepatitis Etiology Number of cases Percentage
HAV 170 66.92
HEV 15 5.90
HBV 17 6.69
Coinfection HAV and HEV 1 0.39
Coinfection HAV and HBV 1 0.39
None 54 21.25
Total 254* 100
*Since two patients have coinfection total number of cases comes out to be 254. 
HAV: Hepatitis A virus, HEV: Hepatitis E virus, HBV: Hepatitis B virus
Table 2: Age distribution of the study population
Age group Total (n=200) Hepatitis A, 
(%)
Hepatitis E, 
(%)
p-value
≤5 years 61 58 (95.08) 1 (1.63) 0.03
5–10 years 78 67 (85.89) 6 (9.8)
≥10 years 61 45 (73.77) 8 (13.11)
Total 200 170 15
Table 3: Clinical presentation and complication profile
Clinical 
presentation/ 
complication
Hepatitis A virus 
(n=170), (%)
Hepatitis E virus 
(n=15), (%)
p-value
Fever 140 (82.35) 12 (80) 0.90
Vomiting 92 (54.11) 8 (53.34) 0.83
Abdominal pain 83 (48.82) 9 (60) 0.57
Anorexia 59 (34.70) 4 (26.67) 0.73
Jaundice 159 (93.52) 13 (86.67) 0.63
Bleeding 21 (12.35) 0 (0) 0.30
Encephalopathy 22 (12.94) 1 (6.67) 0.76
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DISCUSSION
Out of 254 cases taken in this study, 170 cases were positive for 
hepatitis A IgM serology (66.92%) and HEV IgM was positive in 
15 cases (5.90%). Furthermore, 54 patients (21.25%) had none of 
the markers positive in their serological study. A study done by 
Jang et al. found the existence of IgM anti-HAV in 77% of the 
cases and that of IgM anti-HEV in 2% of cases [11]. These results 
were in accordance to the present study. Earlier studies aimed at 
determining the cause of AVH showed HAV positivity 18.7–52%, 
HEV 31–52%, and HBsAg positivity around 11.5%. At present, 
hepatitis E is the most common cause of AVH in adults [12,13]. 
This might be due to the epidemiological shift due to introduction 
of hepatitis A vaccination in Western world. Moreover, with 
improvement in sanitary and hygiene practices, the occurrence of 
hepatitis A has now shifted from early childhood to adolescence.
A number of studies have been conducted in India regarding 
the causative agent of AVH [14-16].
In the present study, the study population was divided into 
three age groups of ≤5 years, 5–10 years, and ≥10 years. The 
maximum cases of AVH and HAV were in the age group of 
5–10 years. However, the highest number of HEV cases was 
in the age group of ≥10 years. It was observed that as the age 
increased proportion of HAV decreased.
These results were similar to findings observed by Escobedo-
Meléndez et al., wherein the mean age was 7.2±3.8 years [17]. 
They showed a significant increase in anti-HAV IgM prevalence in 
the school-aged group and reduction in prevalence of adolescents. 
The mean age in the study by Kumar et al. was 7±3 years [16]. 
In a study by Malathi et al., age distribution was as follows: 
<6 years – 47.9%, 6–10 years – 44.1%, and >10 years – 7.9%; 
however, they included children up to 12 years of age [15]. In 
a similar study by Radhakrishnan et al., HAV positivity was 
52.7% in children <12 years and 9.2% in children >12 years 
and for HEV, it was 5.5% and 18.5%, respectively, which was 
in accordance with the present study [14]. In a study by Singh 
et al., viral marker positive cases were 61.1% in children <6 years 
and 38.9% in children >6 years [18]. Data have shown that HEV 
infection occurs more often in older children and adults while 
HAV occurs mostly in children under 12 years of age.
In our study, the most common clinical presentation was 
jaundice (93%) followed by fever (82.5%), vomiting (55.5%), 
abdominal pain (50.5%), and hepatomegaly (48.5%). Escobedo-
Meléndez et al. found jaundice in 96% and hepatomegaly in 98% 
of cases [17]. The variation in symptoms can be due to geographic 
variation and development status of country. Singh et al. observed 
fever in 92% of cases, jaundice in 100%, and hepatomegaly in 
75.9% of cases.
ALF was found in 63 patients (24.80%) of the total study 
population. Out of these, 42 (66.7%) were due to HAV and 
1 case (1.5%) due to HEV. Escobedo-Meléndez et al. found 3% 
incidence of ALF [17]. In a study of Jang et al., the fulminant 
hepatitis rate was 0.5% which comprised cases of HAV only [11]. 
This finding is in accordance to the epidemiology of hepatitis A 
where it is the leading cause of ALF in developing countries. In 
a study done by Singh et al., fulminant hepatitis was documented 
in 8 of 54 cases (14.8%) [18]. In a study by Malathi et al., 13% of 
children developed hepatic failure and 13% of children died [15].
In our study, hepatitis A and E coinfection was reported in 
1 (0.39%) patient. This was comparatively lower than that 
observed by Joon et al. [19]. Coinfection with HEV and HAV 
did not affect the prognosis as these cases improved after 
symptomatic treatment. Acute hepatitis A is usually improved 
by conservative management, but it was found that coinfection 
of HAV and HEV may lead to severe forms of disease such as 
hepatic encephalopathy [19].
The limitations of the present study include that it was a 
hospital-based study, which may not be representative of the 
community. Furthermore, it was a single-institution research and 
further studies would be needed to test whether the same findings 
are applicable in other areas too.
CONCLUSION
There is no significant difference in enterically-transmitted 
hepatitis viruses. Both cause same symptoms with similar 
examination findings and biochemical profile. Only way to 
differentiate them is by serological tests. Coinfection of hepatitis 
viruses was also detected in some cases.
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